Tamao Nakashita

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis

Shunsuke Furuta, Daiki Nakagomi, Y Kobayashi et al. · JAMA · 2021 · 217 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

Tamao Nakashita, Katsutoshi Ando, Norihiro Kaneko et al. · BMJ Open · 2014 · 121 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection

Nobuhiro Asai, Shinji Motojima, Yoshihiro Ohkuni et al. · Journal of Infection and Chemotherapy · 2012 · 70 citations

Medicine, Clinical Sciences, Infectious Diseases +15

Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients

Tamao Nakashita, Katsutoshi Ando, Kazuhisa Takahashi et al. · Respiratory Investigation · 2016 · 63 citations

Life Sciences, Immunology, Pharmacotherapy +16

Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study

Kei Nakashima, Masahiro Aoshima, Tamao Nakashita et al. · Journal of Microbiology Immunology and Infection · 2017 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10